Paperpal Prime Logo

Biomaterials : Impact Factor & More

eISSN: 1878-5905pISSN: 0142-9612

Aims and Scope of Biomaterials

Biomaterials is a peer-reviewed scientific journal covering research on and applications of biomaterials. It is published by Elsevier and the editor-in-chief is Kam W. Leong (Columbia University). The journal was established in 1980. Less

Key Metrics

CiteScore
21.5
Eigenfactor
0.05 - 0.1
H-Index
418
Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Biophysics
SNIP
2.05
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Biomaterials

Biomaterials Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • Inspec Inspec
  • SJR SJR
Overview
Publisher ELSEVIER SCI LTD
Language English
Frequency Fortnightly
General Details
LanguageEnglish
FrequencyFortnightly
Publication Start Year1980
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Biomaterials ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Biomaterials

Rethinking the PSMA-mediated tumor targeting of nanocarrier and potentiating co-delivery of PARP/EZH2 inhibitors for robust prostate cancer treatment
  • 1 Jan 2027
  • Biomaterials
A mechanism-inspired integrated dual-frequency ultrasound transducer for cavitation-enhanced transdermal drug delivery.
  • 1 Dec 2026
  • Biomaterials
C-di-AMP inhibition-propelled unlocking bacterial cuproptosis accelerates tissue remodeling and confers long-lasting immunoprotection.
  • 1 Dec 2026
  • Biomaterials
Multifunctional immunomodulator with cascade catalytic activities to reprogram endoplasmic reticulum stress-mediated immunosuppression for enhancing anti-tumor immunotherapy.
  • 1 Dec 2026
  • Biomaterials
Corrigendum to "Single-cell RNA-seq reveals functionally distinct biomaterial degradation-related macrophage populations" [Biomaterials Oct:277 (2021) 121116
  • 1 Dec 2026
  • Biomaterials
MOF-based nanoparticles enabling blood-brain barrier crossing for non-invasive selective sononeuromodulation in epilepsy.
  • 1 Dec 2026
  • Biomaterials
Rethinking the PSMA-mediated tumor targeting of nanocarrier and potentiating co-delivery of PARP/EZH2 inhibitors for robust prostate cancer treatment
  • 1 Jan 2027
  • Biomaterials
A mechanism-inspired integrated dual-frequency ultrasound transducer for cavitation-enhanced transdermal drug delivery.
  • 1 Dec 2026
  • Biomaterials
C-di-AMP inhibition-propelled unlocking bacterial cuproptosis accelerates tissue remodeling and confers long-lasting immunoprotection.
  • 1 Dec 2026
  • Biomaterials
Multifunctional immunomodulator with cascade catalytic activities to reprogram endoplasmic reticulum stress-mediated immunosuppression for enhancing anti-tumor immunotherapy.
  • 1 Dec 2026
  • Biomaterials
Corrigendum to "Single-cell RNA-seq reveals functionally distinct biomaterial degradation-related macrophage populations" [Biomaterials Oct:277 (2021) 121116
  • 1 Dec 2026
  • Biomaterials
MOF-based nanoparticles enabling blood-brain barrier crossing for non-invasive selective sononeuromodulation in epilepsy.
  • 1 Dec 2026
  • Biomaterials

FAQs on Biomaterials